Drawing for ALLIVAY

USPTO serial 86315808

ALLIVAY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
STRINGER, DANIEL
Law office
TMEG LAW OFFICE 103

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ALLIVAY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew O. Brady

MATTHEW O. BRADY Allergan, Inc.2525 Dupont DriveIrvine, CA 92612UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Contraceptive preparations; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular diseases and blood pressure; Pharmaceuticals preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antimicrobial preparations for inhibiting microbiological decomposition in pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 2, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 2, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 3, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 30, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 29, 2017EX5GSOU EXTENSION 5 GRANTED—
Nov 17, 2017EXT5SOU EXTENSION 5 FILED—
Nov 17, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 28, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 27, 2017EX4GSOU EXTENSION 4 GRANTED—
Apr 26, 2017ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 20, 2017EXT4SOU EXTENSION 4 FILED—
Apr 20, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 30, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 28, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 27, 2016EX3GSOU EXTENSION 3 GRANTED—
Oct 19, 2016EXT3SOU EXTENSION 3 FILED—
Oct 19, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 1, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 31, 2016EX2GSOU EXTENSION 2 GRANTED—
May 26, 2016EXT2SOU EXTENSION 2 FILED—
May 26, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 29, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 28, 2016EX1GSOU EXTENSION 1 GRANTED—
Jan 17, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 3, 2015NREVNOTICE OF REVIVAL - E-MAILED—
Dec 3, 2015TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Dec 3, 2015PETGPETITION TO REVIVE-GRANTED—
Dec 3, 2015PROATEAS PETITION TO REVIVE RECEIVED—
Nov 27, 2015EXT1SOU EXTENSION 1 FILED—
May 26, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 10, 2015ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Dec 23, 2014ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 25, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 25, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 5, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 22, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 22, 2014ALIEASSIGNED TO LIE—
Oct 1, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 1, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Oct 1, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 1, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 1, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 24, 2014DOCKASSIGNED TO EXAMINER—
Jun 28, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 24, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance